Literature DB >> 9521743

Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.

T Szegletes1, W D Mallender, T L Rosenberry.   

Abstract

The active site gorge of acetylcholinesterase (AChE) contains two sites of ligand binding, an acylation site near the base of the gorge with a catalytic triad characteristic of serine hydrolases, and a peripheral site at the mouth of the gorge some 10-20 A from the acylation site. Many ligands that bind exclusively to the peripheral site inhibit substrate hydrolysis at the acylation site, but the mechanistic interpretation of this inhibition has been unclear. Previous interpretations have been based on analyses of inhibition patterns obtained from steady-state kinetic models that assume equilibrium ligand binding. These analyses indicate that inhibitors bound to the peripheral site decrease acylation and deacylation rate constants and/or decrease substrate affinity at the acylation site by factors of up to 100. Conformational interactions have been proposed to account for such large inhibitory effects transmitted over the distance between the two sites, but site-specific mutagenesis has failed to reveal residues that mediate the proposed conformational linkage. Since examination of individual rate constants in the AChE catalytic pathway reveals that assumptions of equilibrium ligand binding cannot be justified, we introduce here an alternative nonequilibrium analysis of the steady-state inhibition patterns. This analysis incorporates a steric blockade hypothesis which assumes that the only effect of a bound peripheral site ligand is to decrease the association and dissociation rate constants for an acylation site ligand without altering the equilibrium constant for ligand binding to the acylation site. Simulations based on this nonequilibrium steric blockade model were in good agreement with experimental data for inhibition by the peripheral site ligands propidium and gallamine at low concentrations of either acetylthiocholine or phenyl acetate if binding of these ligands slows substrate association and dissociation rate constants by factors of 5-70. Direct measurements with the acylation site ligands huperzine A and m-(N,N, N-trimethylammonio)trifluoroacetophenone showed that bound propidium decreased the association rate constants 49- and 380-fold and the dissociation rate constants 10- and 60-fold, respectively, relative to the rate constants for these acylation site ligands with free AChE, in reasonable agreement with the nonequilibrium steric blockade model. We conclude that this model can account for the inhibition of AChE by small peripheral site ligands such as propidium without invoking any conformational interaction between the peripheral and acylation sites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521743     DOI: 10.1021/bi972158a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.

Authors:  Yves Bourne; Palmer Taylor; Zoran Radić; Pascale Marchot
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

2.  Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations.

Authors:  Stevan Pecic; Marie A McAnuff; Wayne W Harding
Journal:  J Enzyme Inhib Med Chem       Date:  2010-06-28       Impact factor: 5.051

3.  Long route or shortcut? A molecular dynamics study of traffic of thiocholine within the active-site gorge of acetylcholinesterase.

Authors:  Yechun Xu; Jacques-Philippe Colletier; Martin Weik; Guangrong Qin; Hualiang Jiang; Israel Silman; Joel L Sussman
Journal:  Biophys J       Date:  2010-12-15       Impact factor: 4.033

4.  Structural insights into substrate traffic and inhibition in acetylcholinesterase.

Authors:  Jacques-Philippe Colletier; Didier Fournier; Harry M Greenblatt; Jure Stojan; Joel L Sussman; Giuseppe Zaccai; Israel Silman; Martin Weik
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

5.  Effects of Anticholinesterases on Catalysis and Induced Conformational Change of the Peripheral Anionic Site of Murine Acetylcholinesterase.

Authors:  Fan Tong; Rafique M Islam; Paul R Carlier; Ming Ma; Fredrik Ekström; Jeffrey R Bloomquist
Journal:  Pestic Biochem Physiol       Date:  2013-07-01       Impact factor: 3.963

6.  Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics.

Authors:  Yechun Xu; Jacques-Philippe Colletier; Martin Weik; Hualiang Jiang; John Moult; Israel Silman; Joel L Sussman
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

7.  Synthesis and kinetic analysis of some phosphonate analogs of cyclophostin as inhibitors of human acetylcholinesterase.

Authors:  Supratik Dutta; Raj K Malla; Saibal Bandyopadhyay; Christopher D Spilling; Cynthia M Dupureur
Journal:  Bioorg Med Chem       Date:  2010-02-04       Impact factor: 3.641

8.  Synthesis and in silico evaluation of 1N-methyl-1S-methyl-2-nitroethylene (NMSM) derivatives against Alzheimer disease: to understand their interacting mechanism with acetylcholinesterase.

Authors:  M Kannan; P Manivel; K Geetha; J Muthukumaran; H Surya Prakash Rao; R Krishna
Journal:  J Chem Biol       Date:  2012-09-20

Review 9.  Acetylcholinesterase complexes with the natural product inhibitors dihydrotanshinone I and territrem B: binding site assignment from inhibitor competition and validation through crystal structure determination.

Authors:  Jonah Cheung; Veena Beri; Kazuro Shiomi; Terrone L Rosenberry
Journal:  J Mol Neurosci       Date:  2014-02-27       Impact factor: 3.444

10.  Hydrolysis of low concentrations of the acetylthiocholine analogs acetyl(homo)thiocholine and acetyl(nor)thiocholine by acetylcholinesterase may be limited by selective gating at the enzyme peripheral site.

Authors:  Veena Beri; Jeffrey T Auletta; Ghulam M Maharvi; Juanita F Wood; Abdul H Fauq; Terrone L Rosenberry
Journal:  Chem Biol Interact       Date:  2012-10-06       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.